mirvetuximab
immunogen
['mirasol', '$imgn', 'immunogen ']
$imgn today at #asco23, detailed data from our positive phase 3 #mirasol trial will be highlighted in a late-breaking oral presentation. full details here: 
We exist to interrupt the progress of cancer so cancer can't interrupt the lives of our patients. #TargetABetterNow

Policy: https://t.co/MLtPQiuFPo